Combined with our study, SMI can also reprogram glucose metabolism, inhibit cell proliferation, and promote cell apoptosis through the Akt/mTOR/c-Myc signaling pathway, enhance the sensitivity of lung cancer cells to chemotherapy drugs, and improve the mechanism of SMI sensitization towards chemotherapy drugs. Here, MYC is linked to lung carcinoma.